Endovascular therapy provides a relatively safe and effective treatment option for patients with asymptomatic intracranial aneurysms [1].

These "silent" aneurysms pose a significant health risk because they often show no symptoms until a rupture occurs. Modern medical interventions aim to reduce morbidity and mortality by treating these vascular weaknesses before they bleed into the brain.

Dr. Otto Montero, a vascular surgeon at the Cleveland Clinic, said the risk factors and treatment options for these conditions. He said the role of endovascular therapy as a less invasive alternative to traditional open surgery. This approach allows surgeons to treat the aneurysm from within the blood vessel, reducing the trauma associated with cranial surgery.

Data supporting the safety and efficacy of endovascular therapy for unruptured intracranial aneurysms was published in a registry study online on July 30, 2013 [1]. The findings suggest that for many patients, this method is a viable way to stabilize the vessel wall and prevent future ruptures.

While medical techniques advance in the U.S., global access to these procedures varies. Uruguay's Ministry of Public Health said today that the country will provide universal and free access to treatment for cerebral aneurysms, and arteriovenous malformations [2]. This policy aims to remove financial barriers to critical neurological care.

Treatment decisions typically depend on the size, location, and shape of the aneurysm, as well as the patient's overall health. Surgeons must balance the risk of the procedure against the risk of a spontaneous rupture. Endovascular options, such as coiling or stenting, are frequently used to divert blood flow away from the aneurysm sac—a process that minimizes the pressure on the weakened vessel wall.

Public health officials and specialists continue to advocate for early detection through imaging. Identifying these anomalies early allows patients to pursue preventative therapies that can prevent catastrophic strokes.

“Endovascular therapy provides a relatively safe and effective treatment option for patients with asymptomatic intracranial aneurysms.”

The shift toward endovascular therapy represents a transition from invasive neurosurgery to minimally invasive intervention, lowering the recovery time and risk for patients. Furthermore, Uruguay's move toward universal coverage indicates a growing recognition of cerebral aneurysms as a public health priority rather than a luxury medical concern.